Rational Design and Synthesis of Androgen Receptor-Targeted Nonsteroidal Anti-Androgen Ligands for the Tumor-Specific Delivery of a Doxorubicin−Formaldehyde Conjugate
Authors:
- 18 October 2003
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 46 (24) , 5258-5270
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Drug inhibition of angiogenesisCurrent Opinion in Pharmacology, 2002
- The mutator phenotype theory can explain the complex morphology and behaviour of cancersCellular and Molecular Life Sciences, 2002
- Rational therapeutic intervention in cancer: kinases as drug targetsCurrent Opinion in Genetics & Development, 2002
- Clinical Resistance to STI-571 Cancer Therapy Caused by BCR-ABL Gene Mutation or AmplificationScience, 2001
- Vasculogenic Mimicry and Tumor AngiogenesisThe American Journal of Pathology, 2000
- Preclinical activity of 17β-[N-[N′-(2-chloroethyl)-N′-nitrosocarbamoyl]-l-alanyl]-5α-dihydrotestosterone (E91) against tumour colony forming units and haematopoietic progenitor cellsEuropean Journal of Cancer, 1999
- Role of iron in anthracycline cardiotoxicity: new tunes for an old song?The FASEB Journal, 1999
- TOXICITY OF CHEMOTHERAPYHematology/Oncology Clinics of North America, 1996
- Antitumor and antileukemic effects of some steroids and other biologically interesting compounds containing an alkylating agentJournal of Medicinal Chemistry, 1972
- Transplacental Carcinogenesis by StilbestrolNew England Journal of Medicine, 1971